Varex Imaging Corp

Healthcare · Medical Devices

18.50$ +0.1% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Income Statement

Varex Imaging Corp (VREX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Revenue" came in at 211 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size % Per share

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement VREX
Line item	Q3 16	Q4 16	Q1 17	Q2 17	Q3 17	Q4 17	Q1 18	Q2 18	Q3 18	Q4 18	Q1 19	Q2 19	Q3 19	Q4 19	Q1 20	Q2 20	Q3 20	Q4 20	Q1 21	Q2 21	Q3 21	Q4 21	Q1 22	Q2 22	Q3 22	Q4 22	Q1 23	Q2 23	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26	LTM
Revenue	172	157	155	170	216	176	201	191	205	186	196	197	202	200	197	171	170	177	204	211	226	199	215	215	231	206	228	232	227	190	206	209	206	200	213	203	229	210	216	211	865
Cost of Revenue	103	99	97	111	138	115	131	128	146	126	131	136	131	139	139	145	125	120	139	137	151	134	144	141	157	142	156	156	149	133	140	142	139	131	136	136	151	140	143	134	568
Gross Profit	69	59	58	60	78	62	70	63	59	60	64	61	72	61	58	26	45	57	65	74	76	65	71	73	75	63	73	76	78	57	66	67	67	69	77	68	78	70	73	77	297
Research & Development	14	13	14	18	22	20	22	21	21	19	19	21	20	22	21	19	17	17	18	19	18	18	19	20	20	20	23	20	22	21	23	22	22	24	22	21	24	22	22	23	91
Selling, General & Administrative	36	27	20	26	29	28	31	35	32	31	30	31	36	34	35	31	42	34	31	29	34	33	25	30	30	30	34	32	32	32	36	36	34	34	33	33	34	33	36	31	133
Total Operating Expenses	36	40	34	44	51	48	53	56	53	50	50	56	55	57	56	53	58	51	49	48	49	51	44	50	50	50	57	52	54	53	58	58	56	57	55	148	58	54	58	54	225
Operating Income	33	19	24	16	27	14	17	7.3	6.4	10	15	4.6	16	4.6	1.4	-27	-13	6.1	16	26	27	14	27	23	25	13	16	24	24	4.2	7.7	9.3	11	11	22	-81	20	15	14	23	72
Interest Expense	0.7	0.6	1.0	4.2	6.5	5.5	5.6	5.4	5.2	5.1	5.5	5.1	5.4	5.4	4.6	6.9	15	10	10	11	11	9.9	11	9.4	9.4	7.5	7.3	6.7	7.2	4.6	8.1	7.6	7.8	8.2	10	9.0	7.9	7.9	17	5.8	39
Pre-Tax Income	32	18	22	16	18	7.1	16	2.6	0.3	4.1	7.8	-0.6	10	-1.2	-1.1	-40	-31	-4.7	3.2	15	15	3.3	14	14	14	5.4	7.8	17	1.0	-0.6	2.3	0.8	2.5	2.5	11	-87	14	3.8	-6.4	16	28
Income Tax Expense	9.6	7.1	7.4	5.1	3.2	-4.3	3.4	-1.3	-0.4	1.1	1.9	0.7	2.0	0.1	0.7	-12	-4.3	1.6	0.1	3.1	6.0	1.7	6.0	5.1	0.9	2.2	3.5	7.9	-31	-0.2	0.7	-0.7	52	2.6	3.7	2.5	1.9	1.4	1.6	0.3	5.2
Net Income	22	11	15	11	15	11	12	3.8	0.2	3.0	5.8	-1.4	8.1	-1.3	-1.9	-28	-26	-6.4	3.1	12	8.7	1.4	7.6	8.2	13	3.1	4.1	9.1	32	-0.5	1.4	1.4	-50	-0.3	6.9	-89	12	2.3	-8.1	16	22
EBITDA	36	23	30	21	42	23	27	23	20	23	21	13	25	13	14	-24	-6.9	15	23	35	36	21	31	31	31	20	23	32	16	14	17	14	17	18	28	-71	29	19	18	22	87

LTM = last twelve months (sum of the four most recent quarters).

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Income Statement

Cookie settings